JACQUELINE ZGIET: Open Payments
NPI 1730461666 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,976 in 41 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $503 · 2025 $1,976
Food & beverage: $1,976
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $289 |
| Janssen Biotech, Inc. | 2 | $284 |
| Janssen Pharmaceuticals, Inc | 4 | $272 |
| Vanda Pharmaceuticals Inc. | 10 | $256 |
| Neurocrine BioSciences, Inc. | 3 | $203 |
| AstraZeneca Pharmaceuticals LP | 2 | $187 |
| Optinose US, Inc. | 1 | $125 |
| Axsome Therapeutics, Inc. | 1 | $108 |
| Otsuka America Pharmaceutical, Inc. | 5 | $86 |
| Alkermes, Inc. | 2 | $49 |
Products named: CAPLYTA, TREMFYA, SPRAVATO, INGREZZA, FANAPT, REXULTI, Xhance, BREZTRI.
Industry payments across TN — which companies pay providers there.
